Effectiveness of pitavastatin, an HMG-CoA reductase inhibitor, on lipid and glucose metabolism in Japanese patients with type 2 diabetes

被引:0
|
作者
Kawai, Toshihide
Tokui, Mikiya
Funae, Osamu
Meguro, Shu
Yamada, Satoru
Tabata, Mitsuhisa
Shimada, Akira
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A461 / A461
页数:1
相关论文
共 50 条
  • [1] Efficacy of pitavastatin, a new HMG-CoA reductase inhibitor, on lipid and glucose metabolism in patients with type 2 diabetes
    Kawai, T
    Tokui, M
    Funae, O
    Meguro, S
    Yamada, S
    Tabata, M
    Shimada, A
    DIABETES CARE, 2005, 28 (12) : 2980 - 2981
  • [2] Pitavastatin: The Newest HMG-CoA Reductase Inhibitor
    Watson, Karol E.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2010, 11 (01) : 28 - 34
  • [3] Pitavastatin: A New HMG-CoA Reductase Inhibitor
    Wensel, Terri M.
    Waldrop, Bruce A.
    Wensel, Brian
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 507 - 514
  • [4] New and efficient synthesis of the HMG-CoA reductase inhibitor pitavastatin
    Acemoglu, Murat
    Brodbeck, Andre
    Garcia, Angel
    Grimler, Dorninique
    Hassel, Marc
    Riss, Bernhard
    Schreiber, Robert
    HELVETICA CHIMICA ACTA, 2007, 90 (06) : 1069 - 1081
  • [5] Photostability of pitavastatin-A novel HMG-CoA reductase inhibitor
    Grobelny, Pawel
    Viola, Giampietro
    Vedaldi, Daniela
    Dall'Acqua, Francesco
    Gliszczynska-Swiglo, Anna
    Mielcarek, Jadwiga
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 50 (04) : 597 - 601
  • [6] Pitavastatin A New HMG-CoA Reductase Inhibitor for the Treatment of Hypercholesterolemia
    Ahmad, Haniyyah
    Cheng-Lai, Angela
    CARDIOLOGY IN REVIEW, 2010, 18 (05) : 264 - 267
  • [7] Pitavastatin (a HMG-CoA reductase inhibitor) facilitates insulin-induced glucose metabolism in human hepatoma cells
    Yamauchi, K
    Nakamura, J
    Takeuchi, Y
    Shigematsu, S
    Hashizume, K
    DIABETES, 2004, 53 : A324 - A324
  • [8] Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans
    Yamada, I
    Fujino, H
    Shimada, S
    Kojima, J
    XENOBIOTICA, 2003, 33 (07) : 789 - 803
  • [9] The Effects of Pemafibrate in Japanese Patients with Type 2 Diabetes Receiving HMG-CoA Reductase Inhibitors
    Kusunoki, Masataka
    Sakazaki, Takahiko
    Tsutsumi, Kazuhiko
    Miyata, Tetsuro
    Oshida, Yoshiharu
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (05) : 919 - 924
  • [10] Pitavastatin (NK-104), a new HMG-CoA reductase inhibitor
    Isley, WL
    DRUGS OF TODAY, 2001, 37 (09) : 587 - 594